🖼

Figure 2 — Clarifying off-target effects for torcetrapib using network pharmacology and rev

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-323a4a68639d-2
Figure 2 — Clarifying off-target effects for torcetrapib using network pharmacology and rev
Figure 2Figure 2
SAM plot sheet output of the gene expression profiling of the microarray dataset from a study of torcetrapib (GEO: GDS3556). SAM plot sheet illustrated a signature for differentially expressed genes of H295 adrenal carcinoma cells treated with torcetrapib. Red dots represented gene sets up-regulated.
PubMed: paper-323a4a68639d
Metadata
pmidpaper-323a4a68639d
captionSAM plot sheet output of the gene expression profiling of the microarray dataset from a study of torcetrapib (GEO: GDS3556). SAM plot sheet illustrated a signature for differentially expressed genes
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC3547811/bin/1752-0509-6-152-2.jpg
paper_titleClarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.
figure_labelFigure 2
figure_number2
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.